Stem cell therapy shows promise for patients with spinal injuries

Asterias Biotherapeutics Inc. said initial data from a small study showed its lead stem cell therapy could improve mobility in patients paralyzed by a spinal cord injury. The therapy, AST OPC-1, is the first product derived from human embryos to be tested …

[Read the full article here]

Comments are closed.